Disease relevance of Enterocolitis, Neutropenic

• We present a case of neutropenic enterocolitis in a patient with non-small-cell lung cancer who received docetaxel and flavopiridol as part of a phase I clinical trial and review cases in the literature where docetaxel was involved [1].
• CONCLUSIONS: This case indicates that neutropenic enterocolitis may occur in patients with colorectal carcinoma receiving 5-fluorouracil and leucovorin [2].
• Following treatment with cyclophosphamide she developed symptoms and signs of chronic intestinal pseudo-obstruction (CIPO) that was initially thought to be due to a neutropenic enterocolitis [3].
• We describe a patient with rheumatoid arthritis who developed fatal neutropenic enterocolitis complicated by tracheo-oesophageal fistula following treatment with sulphasalazine [4].

High impact information on Enterocolitis, Neutropenic

• Review of the consultation records of the Gastrointestinal Surgical Oncology service at Roswell Park Memorial Institute from 1982 to 1987 revealed 22 patients with a clinical diagnosis of neutropenic enterocolitis [5].
• Owing to suspicion of neutropenic enterocolitis, antibiotic therapy intensified with teicoplanin, fluconazole, metronidazole and pipril [6].
• Neutropenic enterocolitis due to dipyrone use [7].
• This case is the first report of neutropenic enterocolitis associated with the treatment of carboplatin [8].

Chemical compound and disease context of Enterocolitis, Neutropenic

• Fatal neutropenic enterocolitis associated with sulphasalazine therapy for rheumatoid arthritis [4].

References